Tools commonly used in the Transplant-Organs industry for day-to-day tasks and operations.

• Organ preservation solutions
• Tissue forceps
• Scalpels
• Surgical scissors
• Hemostats
• Retractors
• Suction devices
• Microscopes
• Cryogenic storage tanks
• Blood typing kits
• Tissue typing kits
• Antibody screening kits
• Serology testing equipment
• Computerized organ matching systems
• Medical imaging equipment
• Sterilization equipment
• Surgical gloves
• Gowns
• Masks

Common products and services typical of NAICS Code 621991-05, illustrating the main business activities and contributions to the market.

• Heart transplant
• Kidney transplant
• Liver transplant
• Lung transplant
• Pancreas transplant
• Intestine transplant
• Cornea transplant
• Skin transplant
• Bone transplant
• Cartilage transplant

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Organ Transplant Program Certification: This certification is required for hospitals and medical centers that perform organ transplants. It is provided by the Centers for Medicare & Medicaid Services (CMS) and ensures that the facility meets the necessary requirements for organ transplantation.
• Histocompatibility Laboratory Accreditation: This accreditation is required for laboratories that perform tissue typing and crossmatching for organ transplantation. It is provided by the American Society for Histocompatibility and Immunogenetics (ASHI) and ensures that the laboratory meets the necessary standards for accuracy and reliability.
• United Network for Organ Sharing (UNOS) Membership: UNOS is a non-profit organization that manages the national organ transplant system in the US. Membership is required for hospitals and medical centers that perform organ transplants and ensures that they follow the necessary protocols and guidelines.
• Clinical Laboratory Improvement Amendments (CLIA) Certification: This certification is required for laboratories that perform diagnostic testing on human specimens. It is provided by the Centers for Medicare & Medicaid Services (CMS) and ensures that the laboratory meets the necessary quality standards.
• National Marrow Donor Program (NMDP) Membership: NMDP is a non-profit organization that manages the national registry of bone marrow donors and cord blood units. Membership is required for transplant centers that perform bone marrow and cord blood transplants and ensures that they follow the necessary protocols and guidelines.

A concise historical narrative of NAICS Code 621991-05 covering global milestones and recent developments within the United States.

• The history of the Transplant-Organs industry dates back to the early 20th century when the first successful kidney transplant was performed in 1954. The first heart transplant was performed in 1967, and the first liver transplant was performed in 1963. The development of immunosuppressive drugs in the 1980s allowed for more successful transplants, and the industry continued to grow. In recent years, advancements in technology have allowed for more precise and successful transplants, such as the use of 3D printing to create organs. In the United States, the National Organ Transplant Act was passed in 1984, which established a national system for organ donation and transplantation. Since then, the industry has continued to grow, with over 39,000 transplants performed in the United States in 2020 alone.

The anticipated future trajectory of the NAICS 621991-05 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The future outlook for the Transplant-Organs industry in the USA is positive. The demand for organ transplants is expected to increase due to the aging population and the rise in chronic diseases. Technological advancements in the field of organ transplantation, such as 3D printing of organs and gene editing, are expected to improve the success rate of transplants and reduce the risk of rejection. Additionally, the increasing awareness about organ donation and the efforts of government and non-profit organizations to promote organ donation are expected to increase the availability of organs for transplantation. However, the industry may face challenges such as the high cost of organ transplantation and the shortage of skilled healthcare professionals.

Recent groundbreaking advancements and milestones in the Transplant-Organs industry, reflecting notable innovations that have reshaped its landscape.

• Development Of Ex Vivo Lung Perfusion Technology: This technology allows for the preservation and assessment of donor lungs outside of the body, increasing the number of viable lungs available for transplantation.
• Use Of Drones for Organ Transportation: Drones are being used to transport organs from donors to recipients, reducing transportation time and increasing the success rate of transplants.
• Advances In Immunosuppressive Drugs: New immunosuppressive drugs are being developed that are more effective and have fewer side effects, improving the success rate of transplants and reducing the risk of rejection.
• Development Of Artificial Organs: Researchers are developing artificial organs that can be used as a temporary solution while waiting for a transplant or as a permanent solution for patients who are not eligible for a transplant.
• Use Of Stem Cells for Organ Regeneration: Stem cells are being used to regenerate damaged organs, reducing the need for organ transplantation and increasing the success rate of transplants.